SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

Akebia Therapeutics to hold investor meetings at 2026 Wells Fargo conference

Akebia Therapeutics announced CEO John P. Butler and CFO Erik Ostrowski will conduct investor meetings at the 2026 Wells Fargo Healthcare Conference in Boston.

AKBA

CAMBRIDGE, Mass., Sept.

01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc.

NASDAQ:AKBA, a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P.

Butler, Chief Executive Officer and Erik Ostrowski, Chief Financial and Ch…